WMT

95.41

-0.42%↓

COST

967.82

-1.31%↓

TGT

102.36

-2.46%↓

71.86

-0.61%↓

STZ

166.18

+0.93%↑

WMT

95.41

-0.42%↓

COST

967.82

-1.31%↓

TGT

102.36

-2.46%↓

71.86

-0.61%↓

STZ

166.18

+0.93%↑

WMT

95.41

-0.42%↓

COST

967.82

-1.31%↓

TGT

102.36

-2.46%↓

71.86

-0.61%↓

STZ

166.18

+0.93%↑

WMT

95.41

-0.42%↓

COST

967.82

-1.31%↓

TGT

102.36

-2.46%↓

71.86

-0.61%↓

STZ

166.18

+0.93%↑

WMT

95.41

-0.42%↓

COST

967.82

-1.31%↓

TGT

102.36

-2.46%↓

71.86

-0.61%↓

STZ

166.18

+0.93%↑

Home・Akcijų sąrašas・USANA Health Sciences Inc

USANA Health Sciences Inc

Uždarymo kaina

31.32 -3.57

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

31.26

Max

32.64

Pagrindiniai rodikliai
By Trading Economics
Pajamos	4.8M 9.3M
Pardavimai	36M 250M
P/E Sektoriaus vid.	17.654 27.852
Pelnas, tenkantis vienai akcijai	0.73
Pelno marža	3.723
Darbuotojai	1,700
EBITDA	11M 27M

Dividendai
By Dow Jones
Kitas uždarbis	2025-07-22

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	91M 610M
Ankstesnė atidarymo kaina	34.89
Ankstesnė uždarymo kaina	31.32

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

28.405 / 29.84 Palaikymas ir pasipriešinimas

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-14 22:07; UTC

Pagrindinės rinkos jėgos

Trade Desk Rises on S&P 500 Inclusion

2025-07-14 17:06; UTC

Pagrindinės rinkos jėgos

Crypto Assets Rally Ahead of Possible U.S. Legislation

2025-07-14 16:47; UTC

Įsigijimai, susijungimai, perėmimai

NatWest to Sell Stake in Permanent TSB

2025-07-14 23:46; UTC

Rinkos pokalbiai

Nikkei May Rise as Yen Weakens -- Market Talk

2025-07-14 23:38; UTC

Rinkos pokalbiai

Gold Edges Higher Ahead of U.S. CPI Data -- Market Talk

2025-07-14 23:37; UTC

Rinkos pokalbiai

ANZ's Institutional Earnings Likely to Weigh on Outlook -- Market Talk

2025-07-14 23:29; UTC

Rinkos pokalbiai

South32 Bull Eyes Possible Last-Minute Power Deal for Mozal -- Market Talk

2025-07-14 23:29; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2025-07-14 23:02; UTC

Uždarbis

China Vanke: Additional Provision for Asset Impairment Also Among Factors Weighing on Results >000002.SZ

2025-07-14 23:02; UTC

Uždarbis

China Vanke: Weakness in Overall China Real-Estate Sector Weighed on Results >000002.SZ

2025-07-14 23:02; UTC

Uždarbis

China Vanke 1H Loss Was CNY9.85B >000002.SZ

2025-07-14 23:01; UTC

Uždarbis

China Vanke Sees 1H Loss CNY10.0B-Loss CNY12.0B >000002.SZ

2025-07-14 23:01; UTC

Uždarbis

China Vanke Expects 1H Loss to Widen >000002.SZ

2025-07-14 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2025-07-14 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-07-14 20:07; UTC

Rinkos pokalbiai

Cloud Computing Giants Will Be the Winner from Software's Loss -- Market Talk

2025-07-14 20:05; UTC

Rinkos pokalbiai

Adobe and Salesforce May Struggle to Keep Up With AI Agents -- Market Talk

2025-07-14 19:11; UTC

Rinkos pokalbiai

Oil Retreats Despite Trump Threats of Russia Sanctions -- Market Talk

2025-07-14 19:09; UTC

Rinkos pokalbiai

Gold Breaks a 3-Day Win Streak -- Market Talk

2025-07-14 18:59; UTC

Rinkos pokalbiai

Hotter Weather Outlook, LNG Flows Boost U.S. Natural Gas -- Market Talk

2025-07-14 18:30; UTC

Įsigijimai, susijungimai, perėmimai

Synopsys Buy of Ansys Gets China OK. The $35 Billion Deal Is Set to Close. -- Barrons.com

2025-07-14 18:25; UTC

Rinkos pokalbiai

Dollar Gains, Treasury Yields Lose Steam as Trump Threatens Russia -- Market Talk

2025-07-14 18:25; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-14 16:59; UTC

Rinkos pokalbiai

Goldman Sachs Lifts 2H25 Crude Price Views -- Market Talk

2025-07-14 16:53; UTC

Karštos akcijos

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

2025-07-14 16:27; UTC

Rinkos pokalbiai

Oil Falls as Investors Monitor U.S.-EU Trade, Trump's Russia Sanction Threats -- Market Talk

2025-07-14 16:20; UTC

Rinkos pokalbiai

Uždarbis

Auto & Transport Roundup: Market Talk

2025-07-14 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-07-14 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-07-14 16:12; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių USANA Health Sciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.